Publisher Correction: Refinement of an ovine-based immunoglobulin therapy against SARS-CoV-2, with comparison of whole IgG versus F(ab′)2 fragments

• Stephen Findlay‑Wilson,
• Linda Easterbrook,
• Sandra Smith,
• Neville Pope,
• Matthew Aldridge,
• Gareth Humphries,
• Holger Schuhmann,
• Didier Ngabo,
• Emma Rayner,
• Ashley Otter,
• Thomas Coleman,
• Bethany Hicks,
• Rachel Halkerston,
• Kostis Apostolakis,
• Stephen Taylor,
• Susan Fotheringham,
• Amanda Horton,
• Irene CanoCejas,
• Matthew Wand,
• Julia A. Tree,
• Mark Sutton,
• Victoria Graham,
• Roger Hewson,
• Stuart Dowall

Affiliations

Stephen Findlay‑Wilson

UK Health Security Agency (UKHSA)

Linda Easterbrook

UK Health Security Agency (UKHSA)

Sandra Smith

International Therapeutic, Proteins Ltd

Neville Pope

International Therapeutic Proteins Ltd

Matthew Aldridge

MicroPharm Ltd

Gareth Humphries

Native Antigen Company, Langford Locks

Holger Schuhmann

Native Antigen Company, Langford Locks

Didier Ngabo

UK Health Security Agency (UKHSA)

Emma Rayner

UK Health Security Agency (UKHSA)

Ashley Otter

UK Health Security Agency (UKHSA)

Thomas Coleman

UK Health Security Agency (UKHSA)

Bethany Hicks

UK Health Security Agency (UKHSA)

Rachel Halkerston

UK Health Security Agency (UKHSA)

Kostis Apostolakis

UK Health Security Agency (UKHSA)

Stephen Taylor

UK Health Security Agency (UKHSA)

Susan Fotheringham

UK Health Security Agency (UKHSA)

Amanda Horton

UK Health Security Agency (UKHSA)

Irene CanoCejas

UK Health Security Agency (UKHSA)

Matthew Wand

UK Health Security Agency (UKHSA)

Julia A. Tree

UK Health Security Agency (UKHSA)

Mark Sutton

UK Health Security Agency (UKHSA)

Victoria Graham

UK Health Security Agency (UKHSA)

Roger Hewson

UK Health Security Agency (UKHSA)

Stuart Dowall

UK Health Security Agency (UKHSA)